| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2024 | Jan 8, 2024 | RAPT Therapeutics, Inc. | CHIEF SCIENTIFIC OFFICER | Sell | 26.3 | -898 | -3.13% | ✗ | $20.5K |
| Jan 5, 2023 | Jan 9, 2023 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 26.3 | -742 | -3.75% | ✗ | $16.3K |
| May 4, 2022 | May 5, 2022 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 41.3 | -720 | -3.51% | ✓ | $10.8K |
| Apr 11, 2022 | Apr 12, 2022 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 25.0 | -2,647 | -11.79% | ✓ | $61K |
| Jan 3, 2022 | Mar 21, 2022 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 46.3 | -820 | -4.14% | ✗ | $30.1K |
| Mar 11, 2022 | Mar 14, 2022 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 25.0 | -2,648 | -11.79% | ✓ | $63.3K |
| Feb 11, 2022 | Feb 14, 2022 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 25.0 | -2,647 | -11.79% | ✓ | $59.5K |
| Jan 11, 2022 | Jan 13, 2022 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 25.0 | -2,648 | -11.79% | ✓ | $85.2K |
| Dec 10, 2021 | Dec 13, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 25.0 | -2,647 | -11.79% | ✓ | $81.7K |
| Nov 11, 2021 | Dec 10, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 25.0 | -2,648 | -11.79% | ✓ | $94.5K |
| Oct 11, 2021 | Oct 12, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 25.0 | -2,647 | -11.79% | ✓ | $81.5K |
| Sep 10, 2021 | Sep 13, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 25.0 | -2,648 | -11.79% | ✓ | $94.7K |
| Aug 11, 2021 | Aug 12, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 25.0 | -2,647 | -11.79% | ✓ | $82.6K |
| Jul 12, 2021 | Jul 13, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 25.0 | -2,648 | -11.79% | ✓ | $88.8K |
| Jun 11, 2021 | Jun 15, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 28.8 | -2,647 | -11.79% | ✓ | $49.1K |
| May 11, 2021 | May 13, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 28.8 | -2,648 | -11.79% | ✓ | $48.2K |
| May 5, 2021 | May 6, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 32.5 | -2,084 | -9.52% | ✓ | $44.9K |
| Feb 16, 2021 | Feb 17, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 10.0 | -9,877 | -33.27% | ✓ | $209.6K |
| Jan 5, 2021 | Jan 6, 2021 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 28.8 | -2,000 | -10.23% | ✓ | $39.4K |
| Nov 16, 2020 | Nov 18, 2020 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 10.0 | -9,877 | -49.06% | ✓ | $168K |
| Nov 2, 2020 | Nov 3, 2020 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 20.0 | -1,910 | -15.70% | ✓ | $53.6K |
| Aug 17, 2020 | Aug 18, 2020 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 10.0 | -9,877 | -49.06% | ✓ | $236.3K |
| May 15, 2020 | May 18, 2020 | RAPT Therapeutics, Inc. | Chief Scientific Officer | Sell | 10.0 | -9,877 | -49.06% | ✓ | $148.2K |